Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders

globenewswire.com
SLNO The article investigates the sale of Soleno Therapeutics to Neurocrine Biosciences, raising concerns about whether shareholders are receiving fair value. The investigation suggests potential issues with the deal terms. FORA Halper Sadeh LLC is investigating Forian Inc.'s sale to a consortium of investors, questioning if shareholders are obtaining fair value. The investigation implies potential concerns about the transaction's fairness. MKC The article highlights an investigation into McCormick & Company's merger with Unilever's Foods business, suggesting potential concerns about the fairness of the deal for shareholders. The investigation aims to ensure fair consideration. CYCN An investigation is underway regarding Cyclerion Therapeutics' merger with Korsana Biosciences, focusing on whether shareholders are receiving fair value. The firm is looking into potential breaches of fiduciary duties and unfair deal terms.

Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

The proposed transactions may contain terms that could limit superior competing offers.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Soleno Therapeutics, Inc. (NASDAQ: SLNO)’s sale to Neurocrine Biosciences for $53.00 per share in cash. If you are a Soleno shareholder, click here to learn more about your legal rights and options.

Forian Inc. (NASDAQ: FORA)’s sale to a consortium of investors led by Max Wygod, Chairman and Chief Executive Officer, together with certain other senior executives and existing shareholders of the Company, for $2.17 per share in cash. If you are a Forian shareholder, click here to learn more about your rights and options.

McCormick & Company, Incorporated (NYSE: MKC)’s merger with Unilever’s Foods business. Upon closing of the proposed transaction, McCormick shareholders will own 35.0% of the combined company. If you are a McCormick shareholder, click here to learn more about your legal rights and options.

Cyclerion Therapeutics, Inc. (NASDAQ: CYCN)’s merger with Korsana Biosciences, Inc. Upon closing of the proposed transaction, Cyclerion shareholders are expected to own approximately 1.5% of the combined company. If you are a Cyclerion shareholder, click here to learn more about your legal rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

One World Trade Center

85th Floor

New York, NY 10007

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com